Multisystem Inflammatory Syndrome in a Previously Vaccinated Adolescent Female With Sickle Cell Disease

Pediatr Infect Dis J. 2022 Mar 1;41(3):e104-e105. doi: 10.1097/INF.0000000000003444.

Abstract

Multisystem inflammatory syndrome in children (MIS-C) is a serious complication that is observed most commonly in pediatric patients following severe acute respiratory syndrome coronavirus 2 infections. However, the mechanism and predictors of disease are poorly understood. There are no prior reports of MIS-C among patients who have been fully vaccinated, and only a single case of MIS in an adult patient who had received his second shot just 4 days prior to symptom onset. Here, we present an adolescent with sickle cell disease who was fully vaccinated against severe acute respiratory syndrome coronavirus 2 and had no prior history of known or suspected infection, who presented in shock and was ultimately diagnosed with MIS-C. This case highlights the importance of clinical suspicion for MIS-C even when patients are fully vaccinated.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Anemia, Sickle Cell / complications*
  • COVID-19 / complications*
  • COVID-19 / diagnosis
  • COVID-19 / etiology
  • COVID-19 / prevention & control
  • COVID-19 Drug Treatment
  • COVID-19 Vaccines / adverse effects*
  • Diagnosis, Differential
  • Drug Therapy, Combination
  • Female
  • Glucocorticoids / therapeutic use
  • Humans
  • Immunoglobulins, Intravenous / therapeutic use
  • Methylprednisolone / therapeutic use
  • Pandemics
  • SARS-CoV-2
  • Systemic Inflammatory Response Syndrome / diagnosis*
  • Systemic Inflammatory Response Syndrome / drug therapy
  • Systemic Inflammatory Response Syndrome / etiology*
  • Vaccines, Synthetic / adverse effects*
  • mRNA Vaccines / adverse effects*

Substances

  • COVID-19 Vaccines
  • Glucocorticoids
  • Immunoglobulins, Intravenous
  • Vaccines, Synthetic
  • mRNA Vaccines
  • Methylprednisolone

Supplementary concepts

  • pediatric multisystem inflammatory disease, COVID-19 related